Acarbose

This product is an oral hypoglycemic drug. Its hypoglycemic mechanism is to inhibit the competition between small intestinal wall cells and oligosaccharides, and reversibly bind to glucosidase to inhibit the activity of the enzyme, thereby delaying the degradation of carbohydrates, causing slow intestinal glucose absorption, and reducing the increase in postprandial blood sugar.

Acarbose

Combined with diet control to treat type 2 diabetes.

Swallow the whole tablet immediately before eating or chew it with the first few bites of food. The dosage varies from person to person. The generally recommended dosage is: the starting dose is 50 mg each time, 3 times a day. Then gradually increase to 0.1 g each time, 3 times a day. In some cases, it can be increased to 0.2 g each time, 3 times a day. Or follow the doctor's advice.

There is often flatulence and bowel sounds, occasional diarrhea, and rarely abdominal pain. If the diet is not controlled, gastrointestinal side effects may be aggravated. If severe discomfort still occurs after controlling the diet, consult a doctor to reduce the dose temporarily or permanently. In some cases, skin allergic reactions such as erythema, rash, and urticaria may occur.

1. Patients who are allergic to acarbose and/or inactive ingredients. 2. In view of the lack of sufficient data on the efficacy and tolerability of this product for children and adolescents, this product should not be used in patients under 18 years of age. 3. Patients with chronic gastrointestinal disorders with obvious digestive and absorption disorders are contraindicated. 4. Patients with diseases that may be aggravated by intestinal flatulence (such as Roemheld syndrome, severe hernia, intestinal obstruction and intestinal ulcer) are contraindicated. 5. Patients with severe renal impairment (creatinine clearance 25ml/min) are contraindicated. 6. Because there is no data available on the use of this drug in pregnant women, pregnant women should not use this product. 7. After lactating rats took radiolabeled acarbose tablets, a small amount of radioactive substances was found in their milk. In humans,

1. If this product is used together with sulfonylureas, metformin or insulin, blood sugar may drop to the level of hypoglycemia, and the dosage of sulfonylureas, metformin or insulin needs to be reduced. 2. During the period of taking this product, avoid taking antacids, cholestyramine, intestinal adsorbents and digestive enzyme preparations at the same time to avoid affecting the efficacy of this product. 3. Taking neomycin at the same time can further reduce blood sugar after meals and aggravate the gastrointestinal reaction of this product.

Shade, seal, and keep in a cool place

24 months

CSPC Shengxue Glucose Co., Ltd.

• Founded in:

  2002-03-30

• Address:

  No. 48, Shengxue Road, Luancheng District, Shijiazhuang City

• Tax NO.:

  91130124104716871M

• Registered Funds:

  500 million yuan

• Email:

  Log in to view